SBFM Gets Canada Approval

Sunshine Biopharma Inc. (NASDAQ: SBFM ) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Anastrozole tablets of 1mg for the Canadian market. Anastrozole is the generic equivalent of the brand name breast cancer drug, Arimidex®. Anastrozole is a highly prescribed non-steroidal aromatase inhibitor.

It works by lowering estrogen levels in the body to slow down or reverse the growth of specific breast tumors. Anastrozole is standard care for the adjuvant treatment of postmenopausal women with hormone receptor-positive breast cancer. 27 billion in 2025. 97% during the forecast period 2026-2034 ( The Insight Partners ).

1% of the global pharmaceutical market and ranks as sixth largest in the world.